Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Time to Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares gapped up before the market opened on Thursday . The stock had previously closed at $8.5450, but opened at $9.43. Ambu A/S shares last traded at $9.43, with a volume of 750 shares traded.

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 33.68 and a beta of 0.98. The company has a 50-day simple moving average of $10.09 and a two-hundred day simple moving average of $11.70.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.03%. The company had revenue of $246.39 million during the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.